Higher rates of virological relapse after nucleos (t)ide analogue withdrawal in HBeAg-negative versus positive chronic hepatitis B patients: results from a global, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B Study)

被引:0
|
作者
Choi, Hannah S. J. [1 ]
Hirode, Grishma [1 ,2 ,3 ]
Chen, Chien-Hung [4 ]
Su, Tung-Hung [5 ]
Papatheodoridi, Margarita [6 ]
Lens, Sabela [7 ]
Van Hees, Stijn [8 ]
Brakenhoff, Sylvia [9 ]
Chien, Rong-Nan [10 ]
Seto, Wai-Kay [11 ]
Wong, Grace [12 ]
Feld, Jordan [1 ]
Chan, Henry Ly [12 ]
Yuen, Man-Fung [11 ]
Sonneveld, Milan [9 ]
Vanwolleghem, Thomas [8 ]
Forns, Xavier [7 ]
Papatheodoridis, George [6 ]
Kao, Jia-Horng [5 ]
Hsu, Yao-Chun [13 ]
Cornberg, Markus [14 ]
Hansen, Bettina [1 ]
Jeng, Rachel Wen-Juei [10 ]
Janssen, Harry [1 ]
机构
[1] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[3] Toronto Viral Hepatitis Care Network VIRCAN, Toronto, ON, Canada
[4] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[5] Natl Taiwan Univ Hosp, Taipei, Taiwan
[6] Natl & Kapodistrian Univ Athens, Med Sch, Athens, Greece
[7] Hosp Clin Barcelona, Barcelona, Spain
[8] Antwerp Univ Hosp, Antwerp, Belgium
[9] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[10] Chang Gung Mem Hosp, Linkou Med Ctr, Taoyuan, Taiwan
[11] Univ Hong Kong, Hong Kong, Peoples R China
[12] Chinese Univ Hong Kong, Hong Kong, Peoples R China
[13] I Shou Univ, E Da Hosp, Kaohsiung, Taiwan
[14] Hannover Med Sch, Hannover, Germany
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT415
引用
收藏
页码:S861 / S861
页数:1
相关论文
共 50 条
  • [21] HIGH VIROLOGICAL RELAPSE RATE AFTER NUCLEOS(T)IDE ANALOGUE DISCONTINUATION IN CHRONIC HEPATITIS B
    Chi, H.
    Arends, P.
    Wong, D. K.
    Yim, C.
    Hansen, B. E.
    Janssen, H. L. A.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S436 - S436
  • [22] Relapse incidence and severe flares in chronic hepatitis B patients with lymphoma post rituximab-based chemotherapy versus HBeAg-negative hepatitis B patients without cancer after nucleos (t)ide analogue cessation
    Liu, Yen-Chun
    Shih, Yu-Jia
    Jeng, Rachel Wen-Juei
    Hsu, Chao-Wei
    Chien, Rong-Nan
    JOURNAL OF HEPATOLOGY, 2024, 80 : S772 - S772
  • [23] Can nucleos(T)ide analogue (na) therapy ever be stopped in hbeag-negative chronic hepatitis b?
    Hadziyannis S.J.
    Vassilopoulos D.
    Sevastianos V.
    Hadziyannis E.
    Current Hepatology Reports, 2014, 13 (3) : 256 - 263
  • [24] Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?
    Papatheodoridis, George V.
    LIVER INTERNATIONAL, 2013, 33 : 151 - 156
  • [25] Predictors of relapse after cessation of nucleos(t)ide analog treatment in HBeAg-negative chronic hepatitis B patients: A meta-analysis
    Liu, Yun
    Jia, Minglei
    Wu, Shengdi
    Jiang, Wei
    Feng, Yifan
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 86 : 201 - 207
  • [26] Improving the Prediction of Relapse After Nucleos(t)ide Analogue Discontinuation in Patients With Chronic Hepatitis B
    Song, Do Seon
    Jang, Jeong Won
    Yoo, Sun Hong
    Kwon, Jung Hyun
    Nam, Soon Woo
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (04) : E892 - E903
  • [27] Serum HBV RNA levels after nucleos(t)ide analogue therapy withdrawal in HBeAg negative patients with chronic hepatitis B: results from the Toronto STOP Study
    Liem, Kin Seng
    van Boemmel, Florian
    Farag, Mina S.
    Fung, Scott K.
    Wong, David K. H.
    Yim, Colina K.
    Chen, Jiayun
    Rother, Karen
    Berg, Thomas
    Feld, Jordan J.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    HEPATOLOGY, 2019, 70 : 614A - 614A
  • [28] Long-term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg-negative
    He, Dengming
    Guo, Shimin
    Chen, Wen
    Chen, Xianli
    Yan, Guohua
    Wang, Jie
    Li, Maoshi
    Zhu, Peng
    Huang, Hongfei
    Wang, Yuming
    BMC INFECTIOUS DISEASES, 2013, 13
  • [29] Long-term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg-negative
    Dengming He
    Shimin Guo
    Wen Chen
    Xianli Chen
    Guohua Yan
    Jie Wang
    Maoshi Li
    Peng Zhu
    Hongfei Huang
    Yuming Wang
    BMC Infectious Diseases, 13
  • [30] Durability of virological response in HBeAg-positive chronic hepatitis B patients achieving HBeAg seroconversion during nucleos(t)ide analogue treatment
    Wilson, J. L.
    Thompson, A. J. V.
    Bell, S. J.
    Demediuk, B.
    Shaw, G.
    Watson, K. J. R.
    Desmond, P. V.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A306 - A306